Copyright Reports & Markets. All rights reserved.

Global Huntington Disease Protein Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Huntington Disease Protein Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Huntington Disease Protein Market Size Growth Rate by Product
      • 1.4.2 NI-302
      • 1.4.3 NLF-HD
      • 1.4.4 P-301905
      • 1.4.5 IONIS-HTTRx
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Huntington Disease Protein Market Size Growth Rate by End User
      • 1.5.2 Alzheimer's Disease
      • 1.5.3 Kennedy's Disease
      • 1.5.4 Spinocerebellar Ataxia
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Huntington Disease Protein Market Size
      • 2.1.1 Global Huntington Disease Protein Revenue 2014-2025
      • 2.1.2 Global Huntington Disease Protein Sales 2014-2025
    • 2.2 Huntington Disease Protein Growth Rate by Regions
      • 2.2.1 Global Huntington Disease Protein Sales by Regions
      • 2.2.2 Global Huntington Disease Protein Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Huntington Disease Protein Sales by Manufacturers
      • 3.1.1 Huntington Disease Protein Sales by Manufacturers
      • 3.1.2 Huntington Disease Protein Sales Market Share by Manufacturers
      • 3.1.3 Global Huntington Disease Protein Market Concentration Ratio (CR5 and HHI)
    • 3.2 Huntington Disease Protein Revenue by Manufacturers
      • 3.2.1 Huntington Disease Protein Revenue by Manufacturers (2014-2019)
      • 3.2.2 Huntington Disease Protein Revenue Share by Manufacturers (2014-2019)
    • 3.3 Huntington Disease Protein Price by Manufacturers
    • 3.4 Huntington Disease Protein Manufacturing Base Distribution, Product Types
      • 3.4.1 Huntington Disease Protein Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Huntington Disease Protein Product Type
      • 3.4.3 Date of International Manufacturers Enter into Huntington Disease Protein Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Huntington Disease Protein Sales by Product
    • 4.2 Global Huntington Disease Protein Revenue by Product
    • 4.3 Huntington Disease Protein Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Huntington Disease Protein Breakdown Data by End User

    6 North America

    • 6.1 North America Huntington Disease Protein by Countries
      • 6.1.1 North America Huntington Disease Protein Sales by Countries
      • 6.1.2 North America Huntington Disease Protein Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Huntington Disease Protein by Product
    • 6.3 North America Huntington Disease Protein by End User

    7 Europe

    • 7.1 Europe Huntington Disease Protein by Countries
      • 7.1.1 Europe Huntington Disease Protein Sales by Countries
      • 7.1.2 Europe Huntington Disease Protein Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Huntington Disease Protein by Product
    • 7.3 Europe Huntington Disease Protein by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Huntington Disease Protein by Countries
      • 8.1.1 Asia Pacific Huntington Disease Protein Sales by Countries
      • 8.1.2 Asia Pacific Huntington Disease Protein Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Huntington Disease Protein by Product
    • 8.3 Asia Pacific Huntington Disease Protein by End User

    9 Central & South America

    • 9.1 Central & South America Huntington Disease Protein by Countries
      • 9.1.1 Central & South America Huntington Disease Protein Sales by Countries
      • 9.1.2 Central & South America Huntington Disease Protein Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Huntington Disease Protein by Product
    • 9.3 Central & South America Huntington Disease Protein by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Huntington Disease Protein by Countries
      • 10.1.1 Middle East and Africa Huntington Disease Protein Sales by Countries
      • 10.1.2 Middle East and Africa Huntington Disease Protein Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Huntington Disease Protein by Product
    • 10.3 Middle East and Africa Huntington Disease Protein by End User

    11 Company Profiles

    • 11.1 AFFiRiS AG
      • 11.1.1 AFFiRiS AG Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 AFFiRiS AG Huntington Disease Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 AFFiRiS AG Huntington Disease Protein Products Offered
      • 11.1.5 AFFiRiS AG Recent Development
    • 11.2 Ionis Pharmaceuticals, Inc.
      • 11.2.1 Ionis Pharmaceuticals, Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Products Offered
      • 11.2.5 Ionis Pharmaceuticals, Inc. Recent Development
    • 11.3 Neurimmune Holding AG
      • 11.3.1 Neurimmune Holding AG Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Neurimmune Holding AG Huntington Disease Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Neurimmune Holding AG Huntington Disease Protein Products Offered
      • 11.3.5 Neurimmune Holding AG Recent Development
    • 11.4 nLife Therapeutics, S.L.
      • 11.4.1 nLife Therapeutics, S.L. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 nLife Therapeutics, S.L. Huntington Disease Protein Products Offered
      • 11.4.5 nLife Therapeutics, S.L. Recent Development
    • 11.5 reMYND NV
      • 11.5.1 reMYND NV Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 reMYND NV Huntington Disease Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 reMYND NV Huntington Disease Protein Products Offered
      • 11.5.5 reMYND NV Recent Development
    • 11.6 Sangamo BioSciences, Inc.
      • 11.6.1 Sangamo BioSciences, Inc. Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Sangamo BioSciences, Inc. Huntington Disease Protein Products Offered
      • 11.6.5 Sangamo BioSciences, Inc. Recent Development
    • 11.7 UniQure N.V.
      • 11.7.1 UniQure N.V. Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 UniQure N.V. Huntington Disease Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 UniQure N.V. Huntington Disease Protein Products Offered
      • 11.7.5 UniQure N.V. Recent Development
    • 11.8 Voyager Therapeutics, Inc.
      • 11.8.1 Voyager Therapeutics, Inc. Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Voyager Therapeutics, Inc. Huntington Disease Protein Products Offered
      • 11.8.5 Voyager Therapeutics, Inc. Recent Development
    • 11.9 Vybion, Inc.
      • 11.9.1 Vybion, Inc. Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Vybion, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Vybion, Inc. Huntington Disease Protein Products Offered
      • 11.9.5 Vybion, Inc. Recent Development
    • 11.10 WAVE Life Sciences Ltd.
      • 11.10.1 WAVE Life Sciences Ltd. Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 WAVE Life Sciences Ltd. Huntington Disease Protein Products Offered
      • 11.10.5 WAVE Life Sciences Ltd. Recent Development

    12 Future Forecast

    • 12.1 Huntington Disease Protein Market Forecast by Regions
      • 12.1.1 Global Huntington Disease Protein Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Huntington Disease Protein Revenue Forecast by Regions 2019-2025
    • 12.2 Huntington Disease Protein Market Forecast by Product
      • 12.2.1 Global Huntington Disease Protein Sales Forecast by Product 2019-2025
      • 12.2.2 Global Huntington Disease Protein Revenue Forecast by Product 2019-2025
    • 12.3 Huntington Disease Protein Market Forecast by End User
    • 12.4 North America Huntington Disease Protein Forecast
    • 12.5 Europe Huntington Disease Protein Forecast
    • 12.6 Asia Pacific Huntington Disease Protein Forecast
    • 12.7 Central & South America Huntington Disease Protein Forecast
    • 12.8 Middle East and Africa Huntington Disease Protein Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Huntington Disease Protein Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Huntington Disease Protein market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Huntington Disease Protein market based on company, product type, end user and key regions.

      This report studies the global market size of Huntington Disease Protein in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Huntington Disease Protein in these regions.
      This research report categorizes the global Huntington Disease Protein market by top players/brands, region, type and end user. This report also studies the global Huntington Disease Protein market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      AFFiRiS AG
      Ionis Pharmaceuticals, Inc.
      Neurimmune Holding AG
      nLife Therapeutics, S.L.
      reMYND NV
      Sangamo BioSciences, Inc.
      UniQure N.V.
      Voyager Therapeutics, Inc.
      Vybion, Inc.
      WAVE Life Sciences Ltd.

      Market size by Product
      NI-302
      NLF-HD
      P-301905
      IONIS-HTTRx
      Others
      Market size by End User
      Alzheimer's Disease
      Kennedy's Disease
      Spinocerebellar Ataxia
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Huntington Disease Protein market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Huntington Disease Protein market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Huntington Disease Protein companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Huntington Disease Protein submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Huntington Disease Protein are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Huntington Disease Protein market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now